Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Chris Mok and Malik Peiris.
Chris Mok
Connection Strength
2.161
Malik Peiris
  1. Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2 in humans and mice. Eur J Immunol. 2021 09; 51(9):2296-2305.
    View in: PubMed
    Score: 0.238
  2. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 03; 21(3):385-395.
    View in: PubMed
    Score: 0.227
  3. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.221
  4. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep. 2020 06 02; 31(9):107725.
    View in: PubMed
    Score: 0.221
  5. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020 04; 25(16).
    View in: PubMed
    Score: 0.219
  6. Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China. Emerg Infect Dis. 2017 07; 23(8):1332-1340.
    View in: PubMed
    Score: 0.182
  7. Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill. 2017 Jul 06; 22(27).
    View in: PubMed
    Score: 0.181
  8. The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage. Sci Rep. 2017 05 24; 7(1):2352.
    View in: PubMed
    Score: 0.179
  9. Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1302.
    View in: PubMed
    Score: 0.057
  10. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020 10; 21(10):1293-1301.
    View in: PubMed
    Score: 0.056
  11. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020 09 04; 369(6508):1210-1220.
    View in: PubMed
    Score: 0.056
  12. Risk Assessment of the Tropism and Pathogenesis of the Highly Pathogenic Avian Influenza A/H7N9 Virus Using Ex Vivo and In Vitro Cultures of Human Respiratory Tract. J Infect Dis. 2019 07 19; 220(4):578-588.
    View in: PubMed
    Score: 0.052
  13. Tree shrew as a new animal model to study the pathogenesis of avian influenza (H9N2) virus infection. Emerg Microbes Infect. 2018 Oct 10; 7(1):166.
    View in: PubMed
    Score: 0.049
  14. Influenza A(H5N1) Virus Infection in a Child With Encephalitis Complicated by Obstructive Hydrocephalus. Clin Infect Dis. 2018 01 06; 66(1):136-139.
    View in: PubMed
    Score: 0.047
  15. Human Clade 2.3.4.4 A/H5N6 Influenza Virus Lacks Mammalian Adaptation Markers and Does Not Transmit via the Airborne Route between Ferrets. mSphere. 2018 Jan-Feb; 3(1).
    View in: PubMed
    Score: 0.047
  16. Replication of H9 influenza viruses in the human ex vivo respiratory tract, and the influence of neuraminidase on virus release. Sci Rep. 2017 07 24; 7(1):6208.
    View in: PubMed
    Score: 0.045
  17. Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur Respir J. 2017 03; 49(3).
    View in: PubMed
    Score: 0.044
  18. Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015. Emerg Infect Dis. 2015 Dec; 21(12):2278-80.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.